Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit.
The use of sedatives and muscle relaxants is common in the ICU. Therapeutic goals should be carefully established. Monitoring of desired effects and toxic side effects is essential to avoid preventable morbidity.
Durbin
C G
CG
Surgical Intensive Care Unit, University of Virginia, Health Sciences Center, Charlottesville.
D000768:Anesthesia, General; D003422:Critical Care; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D007362:Intensive Care Units; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D009466:Neuromuscular Blocking Agents; D009467:Neuromuscular Depolarizing Agents